Zhong Wenwu

Zhong Wenwu

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2024 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
ZLZhi-Yu Liao
Zhi-Yu Liao
FGFan Gao
Fan Gao
YYYu-Hang Ye
Yu-Hang Ye
QYQian-Hui Yu
Qian-Hui Yu
CYCui Yang
Cui Yang
WLWu Liang
Wu Liang
Substrate-dependent EnT-enabled dearomative [2+2] cycloaddition of aromatic heterocycles/maleimides.

25 April 2023 in Inorganics
Verified
Journal Article
Open access
PDF file
ZWZhong Wenwu
Zhong Wenwu
FFFahimeh Dehghani Firuzabadi
Fahimeh Dehghani Firuzabadi
Younes HanifehpourYounes Hanifehpour
Younes Hanifehpour
XZXue Zeng
Xue Zeng
YFYuanjiao Feng
Yuanjiao Feng
PRPascal Retailleau
Pascal Retailleau
A two-dimensional and bifunctional pillar-layered metal–organic framework (MOF)—with the molecular formula [Zn(cba)(bpdb)]·DMF (2DTMU-1), H2cba = 4,4′-methylenedibenzoic acid, bpdb = 1,4-bis(4-pyridyl)-2,3-diaza-1,3-butadiene—was obtained via the reaction of zinc(II) nitrate with H2cba as the carboxylate linker and bpdb as the N-donor pillar. 2DTMU-1 is based on a binuclear paddlewheel Zn(II) unit complexed by four bridging bidentate (dicarboxylate) V-shaped ligands, which combine to from H2cba; this tetragonal array, which is connected by bpdb with a bridging azine group, presents a pore size of 18 × 12 Å2.

20 March 2023 in Synthesis
Verified
Journal Article
Closed access
PDF file
ZWZhong Wenwu
Zhong Wenwu
CZChangkuo Zhao
Changkuo Zhao
QHQiang Huang
Qiang Huang
LWLvjia Wu
Lvjia Wu
JSJihai Shi
Jihai Shi
LZLei Zhu
Lei Zhu
An I2/DTBP-promoted (3+2) cycloaddition reaction of 2-aminopyridines and chromones is reported. The work provides a simple and efficient approach to access imidazopyridines scaffold in moderate to good yields. I2/DTBP as an initiator and oxidant was used to realize the tandem (3+2) cycloaddition/oxidative aromatization. Available starting materials, excellent functional-group tolerance, potential drug activity of the products, and application in production on a gram scale are advantageous features of this strategy. Moreover, the obtained products provide a key active fragment for the synthesis of cabozantinib analogues, which has the potential to be developed as an anticancer agent.

8 November 2024 in Tetrahedron
Verified
Journal Article
Closed access
QHQiang Huang
Qiang Huang
LZLei Zhu
Lei Zhu
ZSZhonghua Shi
Zhonghua Shi
XJXin Jin
Xin Jin
ZWZhong Wenwu
Zhong Wenwu

28 April 2023 in Acta Poloniae Pharmaceutica - Drug Research
Verified
Journal Article
Open access
YFYuanjiao Feng
Yuanjiao Feng
HMHome Miao
Home Miao
XZXue Zeng
Xue Zeng
ZWZhong Wenwu
Zhong Wenwu